assisTek, a leader in innovative eClinical technology and eSource solutions for clinical research, is delighted to announce the opening of a new office to support its growing team. This expansion will allow assisTek to boost assistance to customers and expand the capacity of the company to sustain its continued growth. New assisTek Office in Bucks … Read more
Neurocentria, Inc., a privately held late-stage biotechnology company developing novel therapies for neurodegenerative and neuropsychiatric disorders, has today announced that Dr. Thomas Südhof, Avram Goldstein Professor in Stanford University School of Medicine and an investigator of the Howard Hughes Medical Institute, has joined the company’s Scientific Advisory Board (SAB). Dr. Südhof’s appointment further strengthens the … Read more
Seegene Technologies, Inc., a subsidiary of Seegene Inc., South Korea’s leading molecular diagnostics company, announced it will change names and begin doing business as Seegene USA, Inc., effective Jan. 1, 2023. The new name reflects an expanding presence in the US for the organization and aligns with a commitment to increase support of the U.S. … Read more
Vivacitas Oncology, Inc. (“Vivacitas” or the “Company”), a privately held oncology company focused on tough-to-treat cancers, is pleased to announce that Dr. Jai Grewal, MD, has agreed to become a new member of their distinguished Neuro-Oncology Advisory Board. Dr. Grewal will be joining Dr. Andrew Lassman, MD, MS, FAAN in the company’s Scientific Advisory Board. Dr. Jai … Read more
BioAccelergy Ventures has signed a joint-development agreement with ExxonMobil Research and Engineering Company (ExxonMobil) to progress development of a new bio-base stock for lubricants manufacturing from seed and vegetable oil. The multi-year agreement aims to demonstrate the feasibility of producing bio-base stocks at a cost-effective commercial scale to reduce greenhouse gas emissions. BioAccelergy will provide its … Read more
Aalto Bio Reagents ltd., a leading developer of critical raw materials and reagents for the development of diagnostic tests globally, announced today that its SARS-CoV-2 n proteins CK6404 and monoclonals CA1360 that are part of numerous rapid assays that are being run in Europe and the U.S. on the screening frontline for detection of COVID-19 … Read more
Gb Sciences, a plant-based research and biopharma technology company, has reported positive results from a study of its potential treatment for cytokine release syndrome (CRS), one of the most dangerous complications of COVID-19. With reports of the arrival of the Omicron variant of the coronavirus in multiple countries, the Gb Sciences team plans to move … Read more
P23 Labs 23 Days of Giving event went off without a hitch and saw over $1300 given out in gasoline at the last Black-Owned gas station on the island. Trena Weeks, P23 Labs Chief Operating Officer said “There is always a need for toy drives, but we wanted to find another way to have a … Read more
Florida Biotech has selected Tampa for its North American headquarters, research and development, and brand operations, citing the region’s strong talent pool, research universities, strong logistics and growing reputation as a center for biotech and life sciences. Florida Biotech is a sustainable wellness innovation company, developing solutions for industry and home focusing on natural compounds … Read more
Recognizing the glacial pace of traditional drug research and development processes and the adverse effect of this on patients, biopharmaceutical company Gb Sciences has taken innovative steps to speed up the process and is developing key relationships to further advance the clinical development of its novel, plant-inspired therapies for the prescription drug market. To expedite … Read more
